bn:17619021n
Noun Named Entity
Categories: Noindexed articles, Nanomedicine, All articles with dead external links, Medical treatment stubs
EN
BIND-014
EN
BIND-014 is a targeted polymeric nanoparticle, and is an investigational therapeutic drug in phase 2 clinical trials for various cancers, e.g. metastatic prostate cancerBIND-014 is an Accurin nanomedicine produced by Bind Therapeutics Inc. Wikipedia
Definitions
Relations
Sources
EN
BIND-014 is a targeted polymeric nanoparticle, and is an investigational therapeutic drug in phase 2 clinical trials for various cancers, e.g. metastatic prostate cancerBIND-014 is an Accurin nanomedicine produced by Bind Therapeutics Inc. Wikipedia
Targeted polymeric nanoparticle Wikidata
Wikipedia
Wikidata